Posts Tagged ‘Harel-Bellan A’

Physical and functional interaction between heterochromatin protein 1alpha and the RNA-binding protein heterogeneous nuclear ribonucleoprotein U.

Ameyar-Zazoua M, Souidi M, Fritsch L, Robin P, Thomas A, Hamiche A, Percipalle P, Ait-Si-Ali S, Harel-Bellan A. Physical and functional interaction between heterochromatin protein 1alpha and the RNA-binding protein heterogeneous nuclear ribonucleoprotein U. J Biol Chem. 2009 Oct 9;284(41):27974-9. Epub 2009 Jul 17.


Differential cooperation between heterochromatin protein HP1 isoforms and MyoD in myoblasts

Yahi H, Fritsch L, Philipot O, Guasconi V, Souidi M, Robin P, Polesskaya A, Losson R, Harel-Bellan A, Ait-Si-Ali S.Differential cooperation between heterochromatin protein HP1 isoforms and MyoD in myoblasts.
J Biol Chem. 2008 Jul 8. [Epub ahead of print]


Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death

Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene. 2008 Jul 10;27(30):4221-32. Epub 2008 Mar 24.


Micro-RNAs and muscle differentiation

Naguibneva I, Polesskaya A, Ameyar-Zazoua M, Souidi M, Groisman R, Cuvellier S, Ait-Si-Ali S, Pritchard LL, Harel-Bellan A. Micro-RNAs and muscle differentiation. J Soc Biol. 2007;201(4):367-76. Epub 2008 Mar 5.


A novel role for an embryonic regulatory protein Lin-28 in adult skeletal muscle differentiation

Polesskaya A, Harel-Bellan A. A novel role for an embryonic regulatory protein Lin-28 in adult skeletal muscle differentiation Med Sci (Paris). 2007 Oct;23(10):796-7.


Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency

Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, Harel-Bellan A. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 2007 May 1;21(9):1125-38.